Chronic mountain sickness: Difference between revisions

(Format)
 
(5 intermediate revisions by 4 users not shown)
Line 1: Line 1:
==Background==
==Background==
*Excessive polycythemia for a given altitude (Hgb >20)
*Excessive [[polycythemia]] for a given altitude (Hgb >20)
*Occurs in pts living at high-altitude who have COPD, sleep apnea or impaired resp drive  
*Occurs in patients living at high-altitude who have [[COPD]], sleep apnea or impaired respiratory drive  


==Clinical Features==
==Clinical Features==
Line 7: Line 7:
*Difficulty thinking
*Difficulty thinking
*Impaired peripheral circulation
*Impaired peripheral circulation
*Drowsiness  
*[[fatigue|Drowsiness]]


==Differential Diagnosis==
==Differential Diagnosis==
{{High altitude DDX}}
{{High altitude DDX}}


==Diagnosis==
==Evaluation==
 
{{Expected SpO2 at altitude}}


==Management==
==Management==
*Phlebotomy  
*Phlebotomy  
*Relocation to lower altitude  
*Relocation to lower altitude  
*Home O2 use
*Home [[O2]] use


==See Also==
==See Also==
Line 26: Line 26:
<references/>
<references/>


[[Category:Environ]]
[[Category:Environmental]]

Latest revision as of 19:27, 2 March 2020

Background

  • Excessive polycythemia for a given altitude (Hgb >20)
  • Occurs in patients living at high-altitude who have COPD, sleep apnea or impaired respiratory drive

Clinical Features

Differential Diagnosis

High Altitude Illnesses

Evaluation

Expected SpO2 and PaO2 levels at altitude[1]

Altitude SpO2 PaO2 (mm Hg)
1,500 to 3,500 m (4,900 to 11,500 ft) about 90% 55-75
3,500 to 5,500 m (11,500 to 18,000 ft) 75-85% 40-60
5,500 to 8,850 m (18,000 to 29,000 ft) 58-75% 28-40

Management

  • Phlebotomy
  • Relocation to lower altitude
  • Home O2 use

See Also

References

  1. Gallagher, MD, Scott A.; Hackett, MD, Peter (August 28, 2018). "High altitude pulmonary edema". UpToDate. Retrieved May 2, 2019.